December 16, 2021
Adapted vaccine approved for tamariki
Medsafe has granted provisional approval for the Pfizer COVID-19 vaccine for children aged 5 to 11 years old.
Medsafe group manager, Chris James, says it’s adapted version of the vaccine used for people aged 12 and older.
The provisional approval is for two doses, given at least 21 days apart.
Health Ministry immunisation programme director Astrid Koornneef says if approved by Cabinet, the rollout is expected to start no later than the end of January 2022.
That includes training and working with the community to roll out the vaccine, including through whānau-based approaches.